Agents useful in treating facioscapulohumeral muscular dystrophy Grant US-11898143-B2 United States of America 13 Feb 2024
Recombinant virus products and methods for inhibition of expression of DUX4 Grant US-11802291-B2 United States of America 31 Oct 2023
COMPOSITIONS AND METHODS FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) Application WO-2022115745-A1 World Intellectual Property Organisation (WIPO) 02 Jun 2022
Antisense oligonucleotides altering DUX4pre-mRNA splicing Application CN-114026234-A China 08 Feb 2022
METHODS FOR DETERMINING THE PRESENCE OR RISK OF DEVELOPING FACIOSCAPULOHUMERAL DYSTROPHY (F… Application US-20210198739-A1 United States of America 01 Jul 2021
GAPMERS AND METHODS OF USING THE SAME FOR TREATMENT OF MUSCULAR DYSTROPHY Application EP-3684378-A4 European Patent Office 16 Jun 2021
Therapeutic agent for sarcopenia and metabolic diseases Grant US-10913949-B2 United States of America 09 Feb 2021
Agents useful in treating facioscapulohumeral muscular dystrophy Grant US-10907157-B2 United States of America 02 Feb 2021
ANTISENSE OLIGONUCLEOTIDE CAPABLE OF ALTERING SPLICING OF DUX4 pre-mRNA Application WO-2021010301-A1 World Intellectual Property Organisation (WIPO) 21 Jan 2021
Recombinant virus products and methods for inhibition of expression of DUX4 Grant US-10301649-B2 United States of America 28 May 2019
Agents useful in treating facioscapulohumeral muscular dystrophy Grant US-9988628-B2 United States of America 05 Jun 2018
RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITION OF EXPRESSION OF DUX4 Application EP-3290055-A3 European Patent Office 30 May 2018
ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF Application WO-2017050836-A1 World Intellectual Property Organisation (WIPO) 30 Mar 2017
Recombinant virus products and methods for inhibition of expression of DUX4 Grant US-9469851-B2 United States of America 18 Oct 2016
RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITION OF EXPRESSION OF DUX4 Application EP-2736539-A4 European Patent Office 08 Apr 2015
RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITION OF EXPRESSION OF DUX4 Application EP-2736539-A1 European Patent Office 04 Jun 2014
Agents useful in treating facioscapulohumeral muscular dystrophy Application EP-2426203-A3 European Patent Office 14 Mar 2012